Tumor induced osteomalacia is usually referred to as a paraneoplastic phenomenon, however, the tumors are usually benign and the symptomatology is due to osteomalacia or rickets. Jan 16, 2007 tumor induced osteomalacia, also known as oncogenic osteomalacia, is a rare paraneoplastic syndrome in which vitamin d resistant osteomalacia occurs due to the presence of a tumor. Report of two cases yeo gab kim, dds, msd, phd, you sung choi, dds, msd. The impairment of bone metabolism causes inadequate bone mineralization. Removal of the tumor is associated with a cure of the lesion. Jun 08, 2011 tumor induced osteomalacia tio is a rare and fascinating paraneoplastic syndrome in which patients present with bone pain, fractures, and muscle weakness. Bgj398 for the treatment of tumorinduced osteomalacia full. We describe herein two tumorinduced osteomalacia tio cases for whom the causative lesions, located in their popliteal fossa, that were not identied in the standard eld of uorine18. Tumorinduced osteomalacia tio is a rare and fascinating paraneoplastic syndrome in which patients present with bone pain, fractures, and muscle weakness. The cause is high blood levels of the recently identified phosphate and vitamin dregulating hormone, fibroblast growth factor 23 fgf23. Tumorinduced osteomalacia and rickets clinical gate. Tumorinduced osteomalacia and the regulation of phosphate.
Laboratory testing was remarkable for low serum phosphorus. Evaluation of tumorinduced osteomalacia with 111in. Article tumorinduced osteomalacia tio also known as. Since her initial diagnosis, msrreceivesmedicaltherapythathas improvedhersymptoms. Since the syndrome was first described by mccance in 1947,1 approximately 102 patients have been reported with this disease. Osteomalacia is a disease characterized by the softening of the bones caused by impaired bone metabolism primarily due to inadequate levels of available phosphate, calcium, and vitamin d, or because of resorption of calcium. It has been reported to occur in patients with hypophosphatemia because of excessive renal phosphate excretion secondary to various types of mesenchymal tumors, including hemangiopericytoma, giant cell tumor, and fibroma. Clinical manifestations include hypophosphatemia, muscle weakness, bone pain, osteomalacia, and fractures. Tumorinduced osteomalacia tio is a paraneoplastic syndrome in which patients present with bone pain, fractures and muscle weakness. Oncogenic osteomalacia associated with mesenchymal tumor in.
Oncogenic osteomalacia is usually associated with benign mesenchymal tumors. Owing to the role of fgf23 in renal phosphate handling and vitamin d synthesis, tio is characterized by decreased renal tubular reabsorption of phosphate. A benign mesenchymal or mixed connective tissue tumor usually phosphaturic mesenchymal tumor and hemangiopericytoma are the most common associated tumors. Oncogenic osteomalacia definition of oncogenic osteomalacia. Tumorinduced osteomalacia tio is a rare paraneoplastic syndrome, characterized by tumor secretion of fibroblast growth. Recent studies have shown that chromosomal translocations causing a fibronectinfgfr1 fn1fgfr1 fusion gene have been identified in 4060% of these tumors. Soon after surgery, she recovered, resumed her normal life, and went back to jogging. Successful treatment of tumorinduced osteomalacia due to an. Tumors induced osteomalaciaa curious case of double trouble.
Tumorinduced osteomalacia orthopaedicsone articles. Tumorinduced osteomalacia tio is a rare paraneoplastic syndrome clinically characterized by bone pain, fractures and muscle weakness. T umor induced osteomalacia is a rare disorder in which rickets or osteomalacia is associated with a tumor. A 77yearold man was suspected of having tumor induced osteomalacia tio because of hypophosphatemia 1. Tumourinduced osteomalacia tio, also known as oncogenic osteomalacia, is a rare paraneoplastic disorder caused by tumours that secrete fibroblast growth factor 23 fgf23. She presented with nontraumatic low back pain and spontaneous bilateral femur fractures. In cases of nonhereditary osteomalacia associated with hypophosphatemia and inadequate response to vitamin d supplementation, one should consider the possibility of tumor induced osteomalacia, a paraneoplastic syndrome caused by small mesenchymal tumors often found in obscure locations. Tumor induced osteomalacia also known as oncogenic osteomalacia is a very rare acquired neoplasm of mesenchymal origin that causes a paraneoplastic syndrome of renal phosphorus loss through the secretion of phosphatonins. Tumour induced osteomalacia tio is a rare paraneoplastic syndrome characterised by severe hypophosphataemia and osteomalacia, with renal phosphate wasting that occurs in association with tumour. Tumorinduced osteomalacia tio is a rare paraneoplasic syndrome with overproduction of fibroblast growth factor 23 as a phosphaturic agent, leading to. Pdf tumorinduced osteomalacia tio, also known as oncogenic osteomalacia, is a rare paraneoplastic. Tumor induced osteomalacia tio is a paraneoplastic syndrome in which patients present with bone pain, fractures and muscle weakness. The histopathologic analysis revealed that the metatarsal lesion was a mesenchymal tumor. A patient with classic clinical and biochemical features of tumor induced osteomalacia hypophosphatemia, phosphaturia, and undetectable serum concentrations of 1,25dihydroxyvitamin d 1,25oh 2 d was studied before and after resection of a benign extraskeletal chondroma from the plantar surface of the foot.
The following case report describes a young woman who seeks a second opinion from a rheumatologist and is found to have oncogenic osteomalacia. Tumorinduced osteomalacia tio is clinically featured by bone pain. We report a case of tumorinduced osteomalacia with evidence of synchronous multifocal fibroblast growth factor 23 fgf23. Mar 28, 2017 several diseases can result in disorders of bone mineralization in children, including rickets, renal diseases renal osteodystrophy, fanconi syndrome, tumor induced osteomalacia, hypophosphatasia, mccunealbright syndrome, and osteogenesis imperfecta with mineralization defect syndrome resembling osteogenesis imperfecta sroi. Tumorinduced osteomalacia caused by a parotid tumor.
Missed causative tumors in diagnosing tumor induced. This study was aimed to assess outcomes of different surgical options of patients with tumor induced osteomalacia at a single. The culprit tumors of tio could produce fibroblast growth. Case report phosphaturic mesenchymal tumour mixed connective.
Tumorinduced osteomalacia unveiling a new hormone nejm. We detected a tumor in his left parotid gland, and the fgf23 level in the left external jugular vein indicated that the tumor overproduced fgf23. Nonspecific symptoms including fatigue, bone pain, and musculoskeletal weakness make the diagnosis elusive and. Tumor induced osteomalacia tio, also known as oncogenic osteomalacia, is a rare paraneoplastic syndrome characterized by bone pain, muscle weakness and fractures associated with persistent hypophosphatemia due to renal phosphate wasting, inappropriately normal or low 1,25oh 2 d and elevated or inappropriately normal fibroblast growth factor 23 fgf23. Sep 21, 2017 tumor induced osteomalacia tio is a rare paraneoplastic syndrome characterized by severe hypophosphatemia and osteomalacia related to abnormal tumor production of fibroblast growth factor 23 fgf23 1, 2. Tumor induced osteomalacia tio is a rare and fascinating paraneoplastic syndrome in which patients present with bone pain, fractures, and muscle weakness. Here, we discuss difficulties in the diagnosis of oncogenic osteomalacia using the example of our own clini.
The purpose of this page is to hopefully communicate with other people that have the same bone disease my husband has and gain some more knowledge on it. The clinical presentation of tio includes bone fractures, bone and muscular pains, and sometimes height and weight loss. The first patient also had aminoaciduria and glucosuria in addition to phosphaturia. Synonyms for tumor induced osteomalacia in free thesaurus. Petct, when merged with isotopic imaging, could localize. Tumor induced osteomalacia is a rare acquired disorder. Tio is usually induced by small, slowly growing tumors of mesenchymal origin phosphaturic mesenchymal tumor mixed connective tissue variant pmtmct. A sherlock holmes approach to diagnosis and management. Article information, pdf download for tumorinduced osteomalacia. Several different disorders cause osteomalacia via mechanisms that result in hypocalcemia, hypophosphatemia, or direct inhibition of the mineralization process. Most of the tumors are phosphaturic mesenchymal tumors pmts, which are small and difficult to detect. The clinical presentation of tio includes bone fractures, bone and muscular pains, and.
Tumorinduced osteomalacia is a rare paraneoplastic syndrome with. Tumorinduced osteomalacia tio, also known oncogenic osteomalacia, is a rare paraneoplastic syndrome of abnormal phosphate and vitamin metabolism caused by typically small endocrine tumors that secrete the phosphaturic hormone, fibro blast growth factor 23 fgf23. The resection of the tumor cured her osseous abnormalities. Biochemical hallmarks of the disorder are hypophosphatemia due to renal phosphate wasting, inappropriately normal or low 1,25dihydroxy vitamin d, and elevated or. Acquired isolated renal phosphate wasting associated with a tumor, known as oncogenic osteomalacia or tumor induced osteomalacia, is a rare paraneoplastic syndrome caused by overproduction of fibroblast growth factor 23. Editorial from the new england journal of medicine tumorinduced osteomalacia unveiling a new hormone. Editorial from the new england journal of medicine tumorinduced osteomalacia.
Thus a stepwise procedure combining functional and anatomical tests. Burosumab improved serum phosphorus, osteomalacia, mobility, and fatigue in the 48week, phase 2 study in adults with tumor induced osteomalacia syndrome. Rare and fascinating paraneoplastic syndrome paraneoplastic syndromes refer to the disorders that accompany benign or malignant tumors but are not directly related to mass effects or in. Tumor induced osteomalacia is a paraneoplastic syndrome caused by a mesenchymal tumor elaborating a hormone that induces renalphosphate wasting. Mohan t shenoy dm resident in endocrinology aimskochi 24. Apr 27, 2018 tumor induced osteomalacia tio is a rare disorder in which fibroblast growth factor fgf23producing neoplasms cause renal phosphate wasting and skeletal disease. Tumor induced osteomalacia tio is a rare paraneoplasic syndrome with overproduction of fibroblast growth factor 23 as a phosphaturic agent, leading to chronic hyperphosphaturia and hypophosphatemia, associated with inappropriately normal or low levels of 1,25dihydroxyvitamin d. Fgf23 levels were significantly increased, and total body magnetic resonance imaging mri revealed a tumor mass located at the distal tibia leading to the diagnosis of tumor induced osteomalacia tio.
It has been shown that complete tumor resection may be curative. Oct 19, 2017 tumor induced osteomalacia is caused by the development of a tumor that releases fibroblast growth factor 23 fgf23. Two patients with mesenchymal tumors had osteomalacia associated with marked hypophosphatemia and renal phosphate wasting. This is an open access article distributed under the terms of the creative commons attributionnoncommercialsharealike 3. Tumorinduced osteomalacia caused by primary fibroblast. Tumorinduced osteomalacia tio is a rare paraneoplastic form of renal phos phate wasting that results in severe hypophosphatemia, a defect in vitamin d. Tumor induced osteomalacia tio also known as oncogenic osteomalacia case followup. Tumorinduced osteomalacia localization by wholebody sestam. Apr 23, 2015 tumor induced osteomalacia tio is a paraneoplastic syndrome resulting in renal phosphate wasting and decreased bone mineralization. Grand rounds clinicians corner at the johns hopkins bayview medical center tumorinduced osteomalacia suzanne m. Tumorinduced osteomalacia tio, also known as oncogenic osteomalacia, is a rare paraneoplastic syndrome characterized by hypophosphatemia resulting from decreased tubular phosphate reabsorption, with a low or inappropriately normal level of active vitamin d. Tumorinduced osteomalacia associated with lesions in the.
The clinical manifestation of oncogenic osteomalacia includes bone pain. Missed causative tumors in diagnosing tumorinduced osteomalacia with 18ffdg petct. Jul, 2017 tumour induced osteomalacia tio, also known as oncogenic osteomalacia, is a rare paraneoplastic disorder caused by tumours that secrete fibroblast growth factor 23 fgf23. Fgf23 is responsible for regulating levels of phosphate and vitamin d in the body by telling the kidneys how much phosphate to absorb and how much phosphate to release from the body in the urine. In our case, a 45yearold male patient had multiple fractures accompanied by hypophosphatemia.
234 185 1238 377 684 622 1021 1352 1430 1470 1060 1341 345 1490 93 458 664 1313 1231 575 1652 1132 759 1295 572 1178 976 937 781 350 93 1138 719